Insmed | INSM - Passività Correnti





Passività Correnti Cambiamento Data
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Cytokinetics USD 181.43M 17.76M 2026-06
DBV Technologies USD 54.3M 2.5M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Novartis USD 31.37B 4.1B 2026-03
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06